Unknown

Dataset Information

0

Mutations in RIT1 cause Noonan syndrome with possible juvenile myelomonocytic leukemia but are not involved in acute lymphoblastic leukemia.


ABSTRACT: Noonan syndrome is a heterogeneous autosomal dominant disorder caused by mutations in at least eight genes involved in the RAS/MAPK signaling pathway. Recently, RIT1 (Ras-like without CAAX 1) has been shown to be involved in the pathogenesis of some patients. We report a series of 44 patients from 30 pedigrees (including nine multiplex families) with mutations in RIT1. These patients display a typical Noonan gestalt and facial phenotype. Among the probands, 8.7% showed postnatal growth retardation, 90% had congenital heart defects, 36% had hypertrophic cardiomyopathy (a lower incidence compared with previous report), 50% displayed speech delay and 52% had learning difficulties, but only 22% required special education. None had major skin anomalies. One child died perinatally of juvenile myelomonocytic leukemia. Compared with the canonical Noonan phenotype linked to PTPN11 mutations, patients with RIT1 mutations appear to be less severely growth retarded and more frequently affected by cardiomyopathy. Based on our experience, we estimate that RIT1 could be the cause of 5% of Noonan syndrome patients. Because mutations found constitutionally in Noonan syndrome are also found in several tumors in adulthood, we evaluated the potential contribution of RIT1 to leukemogenesis in Noonan syndrome. We screened 192 pediatric cases of acute lymphoblastic leukemias (96 B-ALL and 96 T-ALL) and 110 cases of juvenile myelomonocytic leukemias (JMML), but detected no variation in these tumoral samples, suggesting that Noonan patients with germline RIT1 mutations are not at high risk to developing JMML or ALL, and that RIT1 has at most a marginal role in these sporadic malignancies.

SUBMITTER: Cave H 

PROVIDER: S-EPMC4970687 | biostudies-literature | 2016 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Mutations in RIT1 cause Noonan syndrome with possible juvenile myelomonocytic leukemia but are not involved in acute lymphoblastic leukemia.

Cavé Hélène H   Caye Aurélie A   Ghedira Nehla N   Capri Yline Y   Pouvreau Nathalie N   Fillot Natacha N   Trimouille Aurélien A   Vignal Cédric C   Fenneteau Odile O   Alembik Yves Y   Alessandri Jean-Luc JL   Blanchet Patricia P   Boute Odile O   Bouvagnet Patrice P   David Albert A   Dieux Coeslier Anne A   Doray Bérénice B   Dulac Olivier O   Drouin-Garraud Valérie V   Gérard Marion M   Héron Delphine D   Isidor Bertrand B   Lacombe Didier D   Lyonnet Stanislas S   Perrin Laurence L   Rio Marlène M   Roume Joëlle J   Sauvion Sylvie S   Toutain Annick A   Vincent-Delorme Catherine C   Willems Marjorie M   Baumann Clarisse C   Verloes Alain A  

European journal of human genetics : EJHG 20160113 8


Noonan syndrome is a heterogeneous autosomal dominant disorder caused by mutations in at least eight genes involved in the RAS/MAPK signaling pathway. Recently, RIT1 (Ras-like without CAAX 1) has been shown to be involved in the pathogenesis of some patients. We report a series of 44 patients from 30 pedigrees (including nine multiplex families) with mutations in RIT1. These patients display a typical Noonan gestalt and facial phenotype. Among the probands, 8.7% showed postnatal growth retardati  ...[more]

Similar Datasets

| S-EPMC4297285 | biostudies-literature
| S-EPMC5386422 | biostudies-literature
| S-EPMC3419978 | biostudies-literature
| S-EPMC4760689 | biostudies-literature
| S-EPMC3710767 | biostudies-literature
| S-EPMC2738571 | biostudies-literature
| S-EPMC11311611 | biostudies-literature
| S-EPMC8305558 | biostudies-literature
| S-EPMC2755958 | biostudies-literature
| S-EPMC4626387 | biostudies-literature